Undervalued Large-Cap Healthcare Stocks on NYS May 2024

May 31, 2024

Healthcare Sector

The healthcare sector includes companies in biotechnology, pharmaceuticals, hospitals, home and long-term care. It also includes related medical equipment manufacturers and suppliers.

New York Stock Exchange

The New York Stock Exchange, located in New York City, is the largest securities exchange in the world by market capitalization of its listed companies.

Our Valuation

A stock is considered undervalued if it trades at a discount to our valuation. To determine a stock’s intrinsic value, we developed an algorithm that uses 6 valuation models to determine the value of a company.* To learn more about stockcalc’s valuation methods, click here.

Undervalued Healthcare stocks

Stocks in this category are held primarily for potential income and capital appreciation.

For an in-depth look at the fundamentals and valuation of each company, try the stockcalc platform free for 30 days.

SymbolNameClose Price ($)Valuation ($)Difference (%)Average Vol (30D)Market Cap ($M)Yield (%)P/E Ratio
NVST Envista Holdings 18.20 38.73 112.79 2228658 3156 0.00 0.0
BAX Baxter Intl 33.19 70.26 111.68 4856306 16927 3.50 0.0
PRGO Perrigo 27.20 51.38 88.88 1599379 3743 4.03 2720.0
BIO.B Bio-Rad Laboratories 279.91 476.97 70.40 - 7988 0.00 0.0
BIO Bio-Rad Laboratories 285.00 478.57 67.92 222398 8133 0.00 0.0
CVS CVS Health 53.67 86.09 60.40 17802276 68000 4.73 9.4
OGN Organon 20.57 31.71 54.14 2066442 5315 5.44 5.0
AGL Agilon Health 5.76 8.59 49.19 4020540 2381 0.00 0.0
ABBV AbbVie 154.79 191.99 24.03 4816173 274443 3.91 46.1
ZBH Zimmer Biomet Holdings 115.14 138.36 20.17 1338451 23742 0.83 25.0
All data provided as at market close May 28, 2024.

Company Details

Envista Holdings

NVST:NYS

Close Price

18.20

Our Valuation

38.73

% Difference

112.79

Market Cap ($M)

3156

P/E Ratio

0.0

Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments comprising Specialty Products and Technologies and Equipment and Consumables.

Access the stockcalc valuation


Baxter Intl

BAX:NYS

Close Price

33.19

Our Valuation

70.26

% Difference

111.68

Market Cap ($M)

16927

P/E Ratio

0.0

Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment, including hospital beds, to the portfolio, although about half of Hillrom's revenue comes from more digitally connected offerings like its smart beds and Voalte medical communications app.

Access the stockcalc valuation


Perrigo

PRGO:NYS

Close Price

27.20

Our Valuation

51.38

% Difference

88.88

Market Cap ($M)

3743

P/E Ratio

2720.0

Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS.

Access the stockcalc valuation


Bio-Rad Laboratories

BIO.B:NYS

Close Price

279.91

Our Valuation

476.97

% Difference

70.40

Market Cap ($M)

7988

P/E Ratio

0.0

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories.

Access the stockcalc valuation


Access our valuation for these companies and 9,000+ more

Try the stockcalc platform free for 30 days

Sign Up

Bio-Rad Laboratories

BIO:NYS

Close Price

285.00

Our Valuation

478.57

% Difference

67.92

Market Cap ($M)

8133

P/E Ratio

0.0

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories.

Access the stockcalc valuation


CVS Health

CVS:NYS

Close Price

53.67

Our Valuation

86.09

% Difference

60.40

Market Cap ($M)

68000

P/E Ratio

9.4

CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the us. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It also operates a top-tier health insurer (acquired through Aetna) where it serves about 26 million medical members.

Access the stockcalc valuation


Organon

OGN:NYS

Close Price

20.57

Our Valuation

31.71

% Difference

54.14

Market Cap ($M)

5315

P/E Ratio

5.0

Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan.

Access the stockcalc valuation


Agilon Health

AGL:NYS

Close Price

5.76

Our Valuation

8.59

% Difference

49.19

Market Cap ($M)

2381

P/E Ratio

0.0

Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.

Access the stockcalc valuation


AbbVie

ABBV:NYS

Close Price

154.79

Our Valuation

191.99

% Difference

24.03

Market Cap ($M)

274443

P/E Ratio

46.1

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).

Access the stockcalc valuation


Zimmer Biomet Holdings

ZBH:NYS

Close Price

115.14

Our Valuation

138.36

% Difference

20.17

Market Cap ($M)

23742

P/E Ratio

25.0

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, sports medicine, and related surgical products.

Access the stockcalc valuation


Access thousands of valuation reports

Try the stockcalc platform for 30 days for unlimited access to our valuation reports

Sign Up
Envista Holdings and Baxter Intl are the most undervalued Large-Cap Healthcare stocks on the NYS. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-large-cap-healthcare-stocks-nys-may-2024
Envista Holdings $NVST and Baxter Intl $BAX are the most undervalued Healthcare stocks on the #NYS. See the full list: https://www.stockcalc.com/Blog/undervalued-large-cap-healthcare-stocks-nys-may-2024
Envista Holdings and Baxter Intl are the most undervalued Large-Cap Healthcare stocks on the NYS. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-large-cap-healthcare-stocks-nys-may-2024

Copyright © 2016- Patchell Brook Equity Analytics Inc. All rights reserved.

Risk Disclosure: Equities trading and trading of all markets, exchanges and instruments contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. View full risk information here.